Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-04

Clinical Trial Update: TMS for Exposure Therapy Resistant OCD [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating 1 Hz real rTMS to the pre-SMA versus sham rTMS for exposure therapy-resistant obsessive-compulsive disorder and is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: 1 Hz Real rTMS to the Pre-SMA, 1 Hz Sham rTMS to the Pre-SMA | Phase 3 | Status: RECRUITING